OctahydroisoindoleCAS# 21850-12-4 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 21850-12-4 | SDF | Download SDF |
| PubChem ID | 409979 | Appearance | Powder |
| Formula | C8H15N | M.Wt | 125.21 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2,3,3a,4,5,6,7,7a-octahydro-1H-isoindole | ||
| SMILES | C1CCC2CNCC2C1 | ||
| Standard InChIKey | ODSNARDHJFFSRH-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C8H15N/c1-2-4-8-6-9-5-7(8)3-1/h7-9H,1-6H2 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Structure Identification | European Journal of Organic Chemistry, 2011,33:6732–6738.Synthesis of Phosphoproline Derivatives with an Octahydroisoindole Structure[Reference: WebLink]
|
Octahydroisoindole Dilution Calculator
Octahydroisoindole Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 7.9866 mL | 39.9329 mL | 79.8658 mL | 159.7317 mL | 199.6646 mL |
| 5 mM | 1.5973 mL | 7.9866 mL | 15.9732 mL | 31.9463 mL | 39.9329 mL |
| 10 mM | 0.7987 mL | 3.9933 mL | 7.9866 mL | 15.9732 mL | 19.9665 mL |
| 50 mM | 0.1597 mL | 0.7987 mL | 1.5973 mL | 3.1946 mL | 3.9933 mL |
| 100 mM | 0.0799 mL | 0.3993 mL | 0.7987 mL | 1.5973 mL | 1.9966 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- BDNF (human)
Catalog No.:BCC5944
CAS No.:218441-99-7
- Macrocarpal K
Catalog No.:BCN4934
CAS No.:218290-59-6
- Nifedipine
Catalog No.:BCC4808
CAS No.:21829-25-4
- Vindoline
Catalog No.:BCN4933
CAS No.:2182-14-1
- SRPIN340
Catalog No.:BCC4849
CAS No.:218156-96-8
- SC 26196
Catalog No.:BCC7880
CAS No.:218136-59-5
- Isopteleine
Catalog No.:BCN7067
CAS No.:2181-84-2
- Potassium Canrenoate
Catalog No.:BCC3844
CAS No.:2181-04-6
- Thalifoline
Catalog No.:BCN3301
CAS No.:21796-15-6
- Noroxyhydrastinine
Catalog No.:BCN2646
CAS No.:21796-14-5
- Homomangiferin
Catalog No.:BCN8145
CAS No.:21794-66-1
- Diallyl disulfide
Catalog No.:BCN3840
CAS No.:2179-57-9
- Falcarinol
Catalog No.:BCN3938
CAS No.:21852-80-2
- Bardoxolone
Catalog No.:BCC1399
CAS No.:218600-44-3
- Bardoxolone methyl
Catalog No.:BCC1400
CAS No.:218600-53-4
- Boc- ß-HoIle-OH
Catalog No.:BCC3236
CAS No.:218608-82-3
- 12-Hydroxyisodrimenin
Catalog No.:BCN4935
CAS No.:218780-16-6
- Boc-Arg(NO2)-OH
Catalog No.:BCC3065
CAS No.:2188-18-3
- Lycorine chloride
Catalog No.:BCN1220
CAS No.:2188-68-3
- Horminone
Catalog No.:BCN4936
CAS No.:21887-01-4
- Boc-Orn-OH
Catalog No.:BCC3427
CAS No.:21887-64-9
- 1-Phenyloctane
Catalog No.:BCN2227
CAS No.:2189-60-8
- Taraxeryl acetate
Catalog No.:BCN4937
CAS No.:2189-80-2
- Ciwujiatone
Catalog No.:BCN7598
CAS No.:218901-26-9
Total synthesis of (+/-)-kainic acid: a photochemical C-H carbamoylation approach.[Pubmed:21504139]
Org Lett. 2011 May 20;13(10):2674-7.
A novel photochemical C-H carbamoylation of an Octahydroisoindole derivative with PhNCO has allowed the authors to provide a unique access to a highly functionalized proline motif from which total synthesis of (+/-)-kainic acid, a bioactive marine alkaloid, has been accomplished.
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.[Pubmed:3035180]
J Med Chem. 1987 Jun;30(6):992-8.
The synthesis of a series of novel, potent angiotensin converting enzyme (ACE) inhibitors containing saturated bicyclic amino acids in place of proline is described. Octahydroindole-2-carboxylic acid, Octahydroisoindole-1-carboxylic acid, and octahydro-3-oxoisoindole-1-carboxylic acid can replace proline in both sulfhydryl and non-sulfhydryl ACE inhibitors to give compounds equipotent to captopril and enalapril both in vitro and in vivo. Structure-activity relationships are discussed. Compound 11a (CI-907, indolapril) has advanced to clinical evaluation.
